Proteinuria has been established as a marker of kidney damage in experimental studies and clinicians consider an early reduction in albuminuria as indicative of a favorable response to treatment.
New studies are being added to CKD-EPI on a rolling basis. As an example, the details of our study identification and inclusion process for CKD-EPI CT can be found here.
The Center for Health Solutions of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center provides the following validated questionnaires.
